IR Home
Corporate Governance
Policy Disclosures
Shareholders Meeting
News Centre
Bursa Announcements
Reports
Annual Reports
Quarterly Reports
Investor Resources
News Alert
IR Website Terms Of Use
IR Privacy Policy
Bursa Announcements
Stock Name / Code :
BIOHLDG ( 0179 )
BIOHLDG-WA (0179WA)
Year :
2024
2023
2022
2021
2020
Archives
Select date range :
News Type :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Friday - 30 Jun 2023
Notice of Person Ceasing (Section 139 of CA 2016) - MR OOI KENG THYE
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
Wednesday - 28 Jun 2023
Additional Listing Announcement /Subdivision of Shares
Friday - 16 Jun 2023
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING BIOALPHA HOLDINGS BERHAD ("BIOALPHA" OR THE "COMPANY") PROPOSED RENOUNCEABLE RIGHTS ISSUE OF UP TO 639,496,610 WARRANTS ("WARRANT(S)") ON THE BASIS OF 3 WARRANTS FOR EVERY 8 EXISTING ORDINARY SHARES ("BIOALPHA SHARE(S)" OR "SHARE(S)") IN THE COMPANY HELD AT AN ENTITLEMENT DATE TO BE DETERMINED LATER ("PROPOSED RIGHTS ISSUE OF WARRANTS")
Friday - 9 Jun 2023
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING BIOALPHA HOLDINGS BERHAD ("BIOALPHA" OR THE "COMPANY") PROPOSED RENOUNCEABLE RIGHTS ISSUE OF UP TO 639,496,610 WARRANTS ("WARRANT(S)") ON THE BASIS OF 3 WARRANTS FOR EVERY 8 EXISTING ORDINARY SHARES ("BIOALPHA SHARE(S)" OR "SHARE(S)") IN THE COMPANY HELD AT AN ENTITLEMENT DATE TO BE DETERMINED LATER ("PROPOSED RIGHTS ISSUE OF WARRANTS")
Wednesday - 7 Jun 2023
Change in Audit Committee - ENCIK MOHD NASIR BIN ABDULLAH
Change in Boardroom - TAN SRI DATO' DR SYED JALALUDIN BIN SYED SALIM
Change in Boardroom - ENCIK MOHD NASIR BIN ABDULLAH
Change in Nomination Committee - ENCIK MOHD NASIR BIN ABDULLAH
Change in Remuneration Committee - ENCIK MOHD NASIR BIN ABDULLAH
Change in Risk Committee - ENCIK MOHD NASIR BIN ABDULLAH
GENERAL MEETINGS: Outcome of Meeting
Wednesday - 31 May 2023
Quarterly rpt on consolidated results for the financial period ended 31 Mar 2023
Monday - 8 May 2023
OTHERS
BIOALPHA HOLDINGS BERHAD ("BIOALPHA" OR "THE COMPANY") BIOALPHA INTERNATIONAL SDN. BHD AND ITS JOINT VENTURE PARTNER, SHANGHAI-LISTED SUZHOU MEDICALSYSTEM INVESTS FURTHER TO COMMERCIALISE BIOALPHA'S PROPRIETARY HEALTH SUPPLEMENTS IN CHINA
Friday - 28 Apr 2023
Annual Report & CG Report - 2022
«
1
2
3
4
5
6
7
8
9
10
»